Psychedelics
Psilocybin, MDMA, ibogaine, ketamine. Trials, regulation, religious exemptions, state programs.
First reporting in this vertical publishes this week.
In the pipeline
| Program | Sponsor | Phase | Status |
|---|---|---|---|
| MDMA-assisted therapy PTSD | Lykos Therapeutics | NDA Filed | Resubmission planned after CRL |
| COMP360 psilocybin Treatment-resistant depression | Compass Pathways | Phase 3 | Topline data expected |
| MM120 (LSD D-tartrate) Generalized anxiety disorder | Mind Medicine | Phase 3 | Breakthrough designation |
| BPL-003 (intranasal mebufotenin) Treatment-resistant depression | atai / Beckley Psytech | Phase 2 | Topline positive |
| CYB003 (deuterated psilocin) Major depressive disorder | Cybin | Phase 3 | Breakthrough designation |